Brickell Biotech, Inc. (BBI) Financials

NASDAQ Currency in USD Disclaimer

$2.35

north_east NA Past Year
Day's range
$2.21
Day's range
$2.37
$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40MEarning201520152016201620172017201820182019201920202020202120210%0%-5000%-5000%-10000%-10000%-15000%-15000%-20000%-20000%Profit Margin
Profit Margin
Revenue
Earnings

BBI Income statement / Annual

Last year (2021), Brickell Biotech, Inc.'s total revenue was $404,000.00, a decrease of 77.83% from the previous year. In 2021, Brickell Biotech, Inc.'s net income was -$39.54 M. See Brickell Biotech, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012
Period Ended 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Operating Revenue $404,000.00 $1.82 M $7.92 M $1.62 M $13.82 M $14.53 M $20.95 M $15.22 M $7.72 M $17.52 M
Cost of Revenue $0.00 $0.00 $0.00 $1.44 M $6.48 M $6.29 M $10.93 M $10.82 M $12.70 M $0.00
Gross Profit $404,000.00 $1.82 M $7.92 M $186,000.00 $7.34 M $8.24 M $10.02 M $4.39 M -$4.98 M $17.52 M
Gross Profit Ratio 1 1 1 0.11 0.53 0.57 0.48 0.29 -0.65 1
Research and Development Expenses $28.23 M $11.22 M $20.21 M $12.33 M $14.39 M $10.36 M $11.06 M $11.47 M $14.56 M $17.34 M
General & Administrative Expenses $12.42 M $11.58 M $12.17 M $8.94 M $12.81 M $13.35 M $19.29 M $20.38 M $24.51 M $23.61 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $1.44 M $6.48 M $6.29 M $10.93 M $10.82 M $12.70 M $13.06 M
Selling, General & Administrative Expenses $12.42 M $11.58 M $12.17 M $10.38 M $19.29 M $19.64 M $30.22 M $31.20 M $37.21 M $36.67 M
Other Expenses $0.00 $0.00 $0.00 -$1.44 M -$6.48 M -$6.29 M -$10.93 M -$10.82 M -$12.70 M -$13.06 M
Operating Expenses $40.65 M $22.80 M $32.39 M $21.27 M $27.21 M $23.71 M $30.35 M $31.84 M $39.07 M $40.95 M
Cost And Expenses $40.65 M $22.80 M $32.39 M $22.70 M $33.68 M $30.00 M $41.28 M $42.67 M $51.77 M $40.95 M
Interest Income $0.00 $0.00 $0.00 $61,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $69,000.00 $0.00 $2.10 M $1.09 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $22,000.00 $10,000.00 $28,000.00 $151,000.00 $793,000.00 $1.12 M $1.16 M $1.66 M $2.21 M $1.98 M
EBITDA -$40.24 M -$20.98 M -$24.47 M -$19.65 M -$13.39 M -$7.86 M -$8.08 M -$14.83 M -$29.03 M -$23.43 M
EBITDA Ratio -97.48 -11.47 -2.75 -9.26 -0.88 -0.54 -0.39 -0.97 -3.76 -1.19
Operating Income Ratio -97.54 -11.51 -3.09 -12.11 -0.97 -0.63 -0.45 -1.09 -4.06 -1.34
Total Other Income/Expenses Net $770,000.00 $63,000.00 $591,000.00 $3.39 M $426,000.00 $204,000.00 $166,000.00 $134,000.00 $114,000.00 $534,000.00
Income Before Tax -$39.47 M -$20.91 M -$23.88 M -$16.25 M -$12.96 M -$8.97 M -$9.24 M -$16.49 M -$31.24 M -$22.90 M
Income Before Tax Ratio -97.71 -11.48 -3.02 -10.02 -0.94 -0.62 -0.44 -1.08 -4.05 -1.31
Income Tax Expense $69,000.00 $63,000.00 $2.69 M $4.48 M $426,000.00 $204,000.00 $166,000.00 $134,000.00 $114,000.00 $534,000.00
Net Income -$39.54 M -$20.91 M -$23.88 M -$16.25 M -$12.96 M -$8.97 M -$9.24 M -$16.49 M -$31.24 M -$22.90 M
Net Income Ratio -97.88 -11.48 -3.02 -10.02 -0.94 -0.62 -0.44 -1.08 -4.05 -1.31
EPS -22.16 -38.39 -355.43 -234.41 -316.76 -282.12 -317.16 -585.11 -1133.13 -839.1
EPS Diluted -22.16 -38.39 -355.43 -234.41 -316.76 -282.12 -317.16 -585.11 -1133.13 -839.1
Weighted Average Shares Out $1.78 M $544,759.00 $67,178.00 $69,339.00 $40,914.00 $31,806.00 $29,127.00 $28,186.00 $27,568.00 $27,290.00
Weighted Average Shares Out Diluted $1.78 M $544,759.00 $67,178.00 $69,339.00 $40,914.00 $31,806.00 $29,127.00 $28,186.00 $27,568.00 $27,290.00
Link